State Food and Drug Administration: At present, ibuprofen and acetaminophen preparation companies are gradually releasing production capacity

How to “reduce fever” of antipyretic drugs is not effective simply by increasing the supply.

Antipyretics such as ibuprofen and acetaminophen are “hard to find”, and entries such as no, snapped up, out of stock, sold out, and so on are frequently searched. As everyone knows, my country is the world’s largest producer and exporter of ibuprofen raw materials, accounting for one-third of the global production capacity. However, in the case of a sudden increase in market demand, there has been a serious shortage of supply.

In this regard, relevant companies have also expressed their views that they will increase the production of antipyretics such as ibuprofen to ensure that the production capacity will double before the end of the month. However, some manufacturers said that the recent demand has already been equivalent to the output of previous years. It can be seen how urgent the needs of the majority of residents for antipyretics are. It is by no means an easy task for enterprises to expand their production. If production is expanded blindly, resources may be wasted. Because, after the transition period passes smoothly, the demand will inevitably drop sharply, and the newly expanded production capacity will also be idle for a long time. For enterprises, it must be a waste. For the majority of residents, there will also be a phenomenon that expired medicines are everywhere.

The “high fever” of antipyretic drugs has become a task that requires strong measures to “reduce fever”, and it must not be allowed to continue to “high fever”. The continuous “high fever” of antipyretic drugs will not only lead to blind and impulsive behavior of enterprises, which will eventually lead to investment losses and waste of resources, but will also cause the general public to “hoard medicines” too much, produce a large number of expired medicines, and even cause pollution of expired medicines. Once used by criminals, it may also threaten and harm the health and life safety of the majority of residents.

For antipyretics, the effect of simply increasing the supply will not be very good, and the sequelae are relatively large. It is necessary to effectively control the supply of drugs through structural adjustments. First of all, manufacturers need to adjust the supply quantity of each box of medicines. At present, the antipyretics such as ibuprofen on the market are generally packed with 24 capsules per box. Facing the market demand, can the manufacturer adjust the packaging method urgently, from 24 capsules per box to 12 capsules per box, so as to In order to increase the supply quantity and reduce the actual supply of medicines, it can not only meet the needs of more residents to purchase medicines, but also avoid serious waste.

Second, pharmacies have to split and sell the drugs in stock. For pharmacies, it is not necessary to put sales quantity first, but to reduce the number of one-time purchases of residents and control the total supply of antipyretics based on the current reality, after approval by the drug regulatory department, through splitting and other means.

Third, drug regulatory authorities should strengthen market supervision. The supply of antipyretics is tight, and the irregular behavior of pharmacies will also increase. Some pharmacies sell drugs by increasing prices, which seriously disrupts the market order. Especially in online sales, there are more irregular behaviors. Therefore, it is necessary to intensify supervision to ensure that the sales order of antipyretics and other drugs is regulated.

In addition to strengthening the work in the production and sales links, the work in the publicity and guidance link should also be improved, and the role of publicity and guidance should be played well to guide the general public to purchase medicines rationally and use them scientifically. Only by letting the general residents have a correct understanding of antipyretics, can we avoid the phenomenon of rushing to buy antipyretics, and prevent the phenomenon of “high fever” from antipyretics.

This disclosure by the State Food and Drug Administration can be said to reassure many patients. With so many manufacturers and sufficient raw materials, there is no reason to worry about not being able to buy antipyretics.

In fact, in the past few days, many places have adopted many thoughtful measures to ensure the people’s demand for medicines. For example, some places have stopped selling antipyretics in boxes, and some local governments have purchased a lot of medicines to distribute to residents.

In fact, if you don’t stock up, the domestic antipyretics are enough, but many people are overly worried about buying a large amount of medicines, and even some big cities can’t buy them, and they use online platforms to purchase them in pharmacies in small counties or even rural areas. This behavior is also very abhorrent.

I hope that the production of antipyretics will no longer be like masks in early 2020. At that time, many companies blindly introduced equipment to expand production capacity, but in fact they all ended up with huge losses in the end.